Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatric Gastroenterology

Diagnosis and Understanding the Pathology Report

At a Glance

Congenital tufting enteropathy diagnosis combines an intestinal biopsy with MOC31/EpCAM staining and genetic testing. Focal epithelial tufts support the diagnosis but can be sparse, while EPCAM or SPINT2 testing helps identify the genetic cause.

Confirming a diagnosis of Congenital Tufting Enteropathy (CTE) is a process of gathering evidence from your baby’s clinical symptoms, the physical structure of their intestine, and their genetic code. Because the condition is so rare, the diagnosis often relies on specialized laboratory tests that look for very specific “hallmarks” of the disease [1][2].

The Role of Intestinal Biopsy

An intestinal biopsy is the most direct way to see how CTE is affecting your baby’s digestive tract. During this procedure, a doctor takes tiny samples of the intestinal lining to be examined under a microscope by a pathologist.

When you receive the pathology report, you may see several technical terms. Understanding these can help you feel more informed during meetings with your medical team:

  • Villous Atrophy (or Blunting): Normally, the intestinal lining has finger-like projections called villi that absorb nutrients. In CTE, these villi are flattened or shortened (atrophied), which significantly reduces the body’s ability to absorb food. Note: Villous atrophy is not specific to CTE and is seen in many intestinal conditions. [3][1]
  • Crypt Hyperplasia: The “crypts” are the glands at the base of the villi where new cells are born. In CTE, these crypts often become elongated or enlarged as the body tries unsuccessfully to replace the abnormal surface cells [1][2].
  • Focal Epithelial Tufts: This is the “hallmark” of the disease. It refers to small, crowded clusters of cells on the surface of the intestinal lining that look like “tufts” or tear-drops [4][5]. Because these tufts can be sparse or “focal,” pathologists may need to look at multiple samples to find them [5][6]. If the exact word “tufts” is missing from an initial report, it does not completely exclude the diagnosis.

MOC31 (EpCAM) Staining

Pathologists use a specialized test called immunohistochemistry—essentially a chemical “stain”—to see if specific proteins are present in the tissue. For CTE, they often use a stain called MOC31, which looks for the EpCAM protein [7][8].

  • In EPCAM-related CTE: The stain will often show an absence of the EpCAM protein, which supports an EPCAM-related diagnosis [8][3].
  • In SPINT2-related CTE: The protein may be present but not working correctly, or it may be reduced. However, normal EpCAM staining does not rule out the disease, especially for SPINT2-related CTE. This staining is an adjunctive tool, not a definitive confirmation; molecular genetic testing is required [9][10].

Confirming with Genetic Testing

While the biopsy shows the damage, genetic testing identifies the cause. This is the most definitive way to confirm a diagnosis of CTE.

  • Congenital Diarrhea Panels: Doctors usually start with a “multigene panel.” This is a single blood test that checks dozens of genes known to cause diarrhea in infants, including EPCAM and SPINT2 [11].
  • Deletion/Duplication Analysis: Depending on the laboratory, testing may also include copy-number analysis to look for missing or duplicated pieces of DNA, though a negative panel does not perfectly exclude the disease [9][12].
  • Next-Generation Sequencing (NGS): If initial tests are unclear, doctors may use advanced sequencing (like Whole Exome or Whole Genome Sequencing) to look at every gene in your baby’s DNA. This can be especially helpful if the presentation is atypical [13][3].

Empowering Your Advocacy

As a parent, you are an essential part of the diagnostic team. You have the right to request and keep copies of all pathology and genetic reports. Having these documents on hand is invaluable if you ever need to seek a second opinion or coordinate care between different specialists. When you look at the pathology report, look for the terms “tufts,” “villous atrophy,” and the results of the “MOC31” or “EpCAM” stain [7][8]. Seeing these terms confirmed in writing can help you feel more confident that your baby is receiving the correct care for their specific condition.

Common questions in this guide

What findings on an intestinal biopsy may suggest congenital tufting enteropathy?
A biopsy may show villous atrophy or blunting, crypt hyperplasia, and focal epithelial tufts. Focal epithelial tufts are the hallmark finding, but they can be sparse, so pathologists may need to examine multiple samples. Villous atrophy alone is not specific to congenital tufting enteropathy.
Does a normal MOC31 or EpCAM stain rule out congenital tufting enteropathy?
No. Absent EpCAM staining can support an EPCAM-related form, but SPINT2-related disease may have present, reduced, or poorly functioning protein. MOC31/EpCAM staining is an additional clue and does not replace molecular genetic testing.
What genetic testing is used to confirm congenital tufting enteropathy?
Doctors commonly begin with a congenital diarrhea multigene panel that includes EPCAM and SPINT2. Testing may also include deletion and duplication analysis. If results are negative or unclear, whole-exome or whole-genome sequencing may be considered, especially when the presentation is atypical.
What if my child’s pathology report does not mention epithelial tufts?
The absence of the word “tufts” does not completely exclude congenital tufting enteropathy because the findings may be focal or missed in a small sample. Ask whether a pediatric gastrointestinal pathologist reviewed the tissue and whether additional samples or specialized staining are appropriate.
Why should parents keep copies of the pathology and genetic reports?
Copies help you understand the diagnosis, obtain a second opinion, and coordinate care among specialists. Keep both physical or digital versions and share them with your child’s medical team when needed.

Get notified when new evidence is published on Congenital tufting enteropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Congenital Tufting Enteropathy: Biology, Pathogenesis and Mechanisms.

    Das B, Sivagnanam M

    Journal of clinical medicine 2020; (10(1)) doi:10.3390/jcm10010019.

    PMID: 33374714
  2. 2

    Tufting Enteropathy: A Review of Clinical and Histological Presentation, Etiology, Management, and Outcome.

    Cai C, Chen Y, Chen X, Ji F

    Gastroenterology research and practice 2020; (2020()):5608069 doi:10.1155/2020/5608069.

    PMID: 33029133
  3. 3

    Novel Mutations in EPCAM Cause Congenital Tufting Enteropathy.

    Tang W, Huang T, Xu Z, Huang Y

    Journal of clinical gastroenterology 2018; (52(1)):e1-e6 doi:10.1097/MCG.0000000000000739.

    PMID: 27875355
  4. 4

    Liver Pathology, Including MOC31 Immunohistochemistry, in Congenital Tufting Enteropathy.

    Chen S, Goldsmith JD, Fawaz R, et al.

    The American journal of surgical pathology 2021; (45(8)):1091-1097 doi:10.1097/PAS.0000000000001710.

    PMID: 33756496
  5. 5

    Tufting enteropathy: a rare anatomical cause of small bowel diarrhoea in infants with mild or no villous abnormality.

    Das P, Malik R, Kaul S, Makharia GK

    Gastroenterology and hepatology from bed to bench 2023; (16(2)):225-229 doi:10.22037/ghfbb.v16i1.2731.

    PMID: 37554749
  6. 6

    [Tufting enteropathy: a case report, histopathological methodology, and differential diagnoses].

    Bosaleh A, Contreras M, García de Dávila MT

    Acta gastroenterologica Latinoamericana 2015; (45(1)):65-9.

    PMID: 26076517
  7. 7

    Three cases of tufting enteropathy and review of literature.

    Noyan A, Gümüş E, Hızarcıoğlu Gülşen H, et al.

    The Turkish journal of pediatrics 2026; (68(2)):337-344 doi:10.24953/turkjpediatr.2026.5607.

    PMID: 42172468
  8. 8

    Three patients with new mutations in the EPCAM variant gene for congenital tufting enteropathy and a mutation review in China: a case report.

    Wang SN, Fu YJ, Lu XL, et al.

    Translational pediatrics 2024; (13(8)):1486-1495 doi:10.21037/tp-24-97.

    PMID: 39263299
  9. 9

    Three Novel EPCAM Variants Causing Tufting Enteropathy in Three Families.

    Ayyıldız Civan H, Leitner C, Östreicher I, et al.

    Children (Basel, Switzerland) 2021; (8(6)) doi:10.3390/children8060503.

    PMID: 34198699
  10. 10

    Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy.

    Szabo R, Callies LK, Bugge TH

    Development (Cambridge, England) 2019; (146(22)) doi:10.1242/dev.183392.

    PMID: 31628112
  11. 11

    NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders.

    Esposito MV, Comegna M, Cernera G, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020262.

    PMID: 33567694
  12. 12

    Identification of EPCAM mutation: clinical use of microarray.

    Tan QK, Cardona DM, Rehder CW, McDonald MT

    Clinical case reports 2017; (5(6)):980-985 doi:10.1002/ccr3.914.

    PMID: 28588851
  13. 13

    Genomic analysis of an infant with intractable diarrhea and dilated cardiomyopathy.

    Bodian DL, Vilboux T, Hourigan SK, et al.

    Cold Spring Harbor molecular case studies 2017; (3(6)) doi:10.1101/mcs.a002055.

    PMID: 28701297

This page explains congenital tufting enteropathy biopsy and genetic testing for informational purposes only and does not constitute medical advice. Your child’s pediatric gastroenterologist, pathologist, and genetics team should interpret the report and guide care.